GSK‐3β inhibitor TDZD‐8 reduces neonatal hypoxic‐ischemic brain injury in mice

AIMS: Glycogen synthase kinase 3β (GSK‐3β) is activated following hypoxic‐ischemic (HI) brain injury. TDZD‐8 is a specific GSK‐3β inhibitor. Currently, the impact of inhibiting GSK‐3β in neonatal HI injury is unknown. We aimed to investigate the effect of TDZD‐8 following neonatal HI brain injury. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Huang, Sammen, Wang, Haitao, Turlova, Ekaterina, Abussaud, Ahmed, Ji, Xiang, Britto, Luiz R., Miller, Steven P., Martinez, Ana, Sun, Hong‐Shuo, Feng, Zhong‐Ping
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492674/
https://ncbi.nlm.nih.gov/pubmed/28256059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados